3SBio Inc. 1530.HK Stock
3SBio Inc. Price Chart
3SBio Inc. 1530.HK Financial and Trading Overview
| 3SBio Inc. stock price | 5.93 HKD |
| Previous Close | 7.3 HKD |
| Open | 7.22 HKD |
| Bid | 7.43 HKD x 0 |
| Ask | 7.44 HKD x 0 |
| Day's Range | 7.22 - 7.58 HKD |
| 52 Week Range | 4.86 - 9.1 HKD |
| Volume | 10.05M HKD |
| Avg. Volume | 5.93M HKD |
| Market Cap | 18.22B HKD |
| Beta (5Y Monthly) | 0.983141 |
| PE Ratio (TTM) | 9.185185 |
| EPS (TTM) | 0.67 HKD |
| Forward Dividend & Yield | 0.1 (1.37%) |
| Ex-Dividend Date | June 27, 2023 |
| 1y Target Est | 9.79 HKD |
1530.HK Valuation Measures
| Enterprise Value | 17.26B HKD |
| Trailing P/E | 9.185185 |
| Forward P/E | 14.588236 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6563537 |
| Price/Book (mrq) | 1.376758 |
| Enterprise Value/Revenue | 2.516 |
| Enterprise Value/EBITDA | 7.603 |
Trading Information
3SBio Inc. Stock Price History
| Beta (5Y Monthly) | 0.983141 |
| 52-Week Change | 12.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.1 HKD |
| 52 Week Low | 4.86 HKD |
| 50-Day Moving Average | 7.83 HKD |
| 200-Day Moving Average | 7.43 HKD |
1530.HK Share Statistics
| Avg. Volume (3 month) | 5.93M HKD |
| Avg. Daily Volume (10-Days) | 4.08M HKD |
| Shares Outstanding | 2.44B |
| Float | 1.71B |
| Short Ratio | N/A |
| % Held by Insiders | 28.03% |
| % Held by Institutions | 19.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.088 |
| Trailing Annual Dividend Yield | 1.20% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2308 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 27.91% |
| Operating Margin (ttm) | 27.82% |
| Gross Margin | 82.68% |
| EBITDA Margin | 33.09% |
Management Effectiveness
| Return on Assets (ttm) | 5.79% |
| Return on Equity (ttm) | 12.69% |
Income Statement
| Revenue (ttm) | 6.86B HKD |
| Revenue Per Share (ttm) | 2.81 HKD |
| Quarterly Revenue Growth (yoy) | 15.09% |
| Gross Profit (ttm) | 5.67B HKD |
| EBITDA | 2.27B HKD |
| Net Income Avi to Common (ttm) | 1.91B HKD |
| Diluted EPS (ttm) | 0.81 |
| Quarterly Earnings Growth (yoy) | 27.70% |
Balance Sheet
| Total Cash (mrq) | 7.01B HKD |
| Total Cash Per Share (mrq) | 2.92 HKD |
| Total Debt (mrq) | 4.47B HKD |
| Total Debt/Equity (mrq) | 29.02 HKD |
| Current Ratio (mrq) | 5.441 |
| Book Value Per Share (mrq) | 5.404 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18B HKD |
| Levered Free Cash Flow (ttm) | 1.06B HKD |
Profile of 3SBio Inc.
| Country | Hong Kong |
| State | N/A |
| City | Shenyang |
| Address | No. 3 A1, Road 10 |
| ZIP | N/A |
| Phone | 86 24 2538 6000 |
| Website | https://www.3sbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5213 |
3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis. It also offers YISAIPU, the receptor-antibody fusion tumor necrosis factor inhibitor; Mendi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium; and Xenopax, a recombinant humanized anti-cd25 monoclonal antibody injection for prevention of acute rejection after renal transplantation. In addition, the company provides TPO-105 Pediatric ITP; SSS12 Cinacalcet hydrochloride; SSS13 Sevelamer carbonate; 301S TNFR-Fc protein; AP506 Apremilast; SSS32 Tofacitinib; and MN709 Minoxidil Foam. Further, the company provides trading, project management and consultation, technology, sports, financial, investment advisory, and agricultural services. It has collaboration agreements with companies, such as Toray Industries Inc, and Toray. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.
Q&A For 3SBio Inc. Stock
What is a current 1530.HK stock price?
3SBio Inc. 1530.HK stock price today per share is 5.93 HKD.
How to purchase 3SBio Inc. stock?
You can buy 1530.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 3SBio Inc.?
The stock symbol or ticker of 3SBio Inc. is 1530.HK.
Which industry does the 3SBio Inc. company belong to?
The 3SBio Inc. industry is Biotechnology.
How many shares does 3SBio Inc. have in circulation?
The max supply of 3SBio Inc. shares is 2.44B.
What is 3SBio Inc. Price to Earnings Ratio (PE Ratio)?
3SBio Inc. PE Ratio is 8.85074600 now.
What was 3SBio Inc. earnings per share over the trailing 12 months (TTM)?
3SBio Inc. EPS is 0.67 HKD over the trailing 12 months.
Which sector does the 3SBio Inc. company belong to?
The 3SBio Inc. sector is Healthcare.
3SBio Inc. 1530.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}